maralixibat
General
Genetic Implications: 
Pronunciation: 
mar-a-lix--i-bat
Trade Name(s)
- Livmarli
 
Ther. Class.
none assigned
Pharm. Class.
temporary class
ileal bile acid transporterThere's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Maralixibat." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Anesthesia Central, anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580060/6/maralixibat. 
Vallerand AHA, Sanoski CAC,  . Maralixibat. Davis's Drug Guide. F.A. Davis Company; 2025. https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580060/6/maralixibat. Accessed November 3, 2025.
Vallerand, A. H., Sanoski, C. A., & ,  (2025). Maralixibat. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580060/6/maralixibat
Vallerand AHA, Sanoski CAC,  . Maralixibat [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 November 03]. Available from: https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580060/6/maralixibat.
* Article titles in AMA citation format should be in sentence-case
TY  -  ELEC
T1  -  maralixibat
ID  -  3580060
A1  -  Sanoski,Cynthia A,
AU  -  Vallerand,April Hazard,
AU  -  ,,
BT  -  Davis's Drug Guide
UR  -  https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580060/6/maralixibat
PB  -  F.A. Davis Company
ET  -  19
DB  -  Anesthesia Central
DP  -  Unbound Medicine
ER  -  

Davis's Drug Guide

